Elsevier

Surgery for Obesity and Related Diseases

Volume 3, Issue 1, January–February 2007, Pages 97-102
Surgery for Obesity and Related Diseases

Review
Venous thromboembolism in bariatric surgery patients: an update of risk and prevention

https://doi.org/10.1016/j.soard.2006.10.002Get rights and content

Section snippets

Incidence of VTE in bariatric surgery population

Bariatric surgical procedures are associated with 30-day overall mortality rates of .1–2% [6], [7]. Retrospective analyses spanning 16–24-year periods have reported an incidence of fatal PE after obesity surgery of .2–.3% [1], [3]. The incidence of postoperative DVT has been reported to be 0–1% [1], [4], [8], [9] and the incidence of symptomatic VTE to be .8–2.4% [1], [4].

A survey of North American bariatric surgeons found that 86% of the 128 respondents considered their patients to be at high

Risk factors for VTE in bariatric surgery patients

Patients undergoing bariatric surgery have an inherent increased risk of thromboembolism. An epidemiologic study of risk factors for VTE has shown that obesity confers an intrinsic and significant risk of symptomatic DVT [10]. Abdominal operations requiring general anesthesia for >30 minutes also confer thrombotic risk, increasing the odds ratio for the development of VTE by >10 (Table 1)[11]. Increasing age has also been identified as a risk factor for adverse events after bariatric surgery,

Options for VTE prophylaxis in bariatric surgery patients

A paucity of grade 1A thromboprophylaxis data specific to bariatric surgery patients is available, and specific recommendations from the American College of Chest Physicians (ACCP) for prophylaxis in this setting are lacking. The ACCP publishes clinical practice guidelines on the basis of a systematic review of peer-reviewed published reports [24]. The strength of the recommendations and quality of the evidence are formally graded. The guidelines undergo formal peer review before review by the

Dosing, duration, and timing of prophylaxis

Given the paucity of data from randomized, controlled clinical trials of obese surgical patients, consensus is lacking about the optimal dosing, timing, and duration of thromboprophylaxis in patients undergoing bariatric surgery.

Conclusion

All patients undergoing bariatric surgery are at a moderate to high risk of postoperative VTE. These patients warrant thromboprophylaxis in accordance with the ACCP recommendations for moderate- to high-risk patient groups. Obesity and surgery are both recognized risk factors for VTE; therefore, patients who are candidates for bariatric surgery should be assessed for additional risk factors that may elevate their VTE risk. Prophylaxis with UFH or LMWH in the peri- and postoperative period is

Acknowledgments

The authors received editorial/writing support in the preparation of this report; this was funded by Sanofi-Aventis, NJ. The authors, however, were fully responsible for the content of, and editorial decisions for, this report.

First page preview

First page preview
Click to open first page preview

References (55)

  • M. Heizmann et al.

    Anti-Xa activity in obese patients after double standard dose of nadroparin for prophylaxis

    Thromb Res

    (2002)
  • C. Kearon

    Duration of venous thromboembolism prophylaxis after surgery

    Chest

    (2003)
  • S. Eriksson et al.

    The incidence of clinical postoperative thrombosis after gastric surgery for obesity during 16 years

    Obes Surg

    (1997)
  • J. Melinek et al.

    Autopsy findings following gastric bypass surgery for morbid obesity

    Arch Pathol Lab Med

    (2002)
  • J.A. Sapala et al.

    Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis

    Obes Surg

    (2003)
  • A. Westling et al.

    Incidence of deep venous thrombosis in patients undergoing obesity surgery

    World J Surg

    (2002)
  • E.C. Wu et al.

    Current practices in the prophylaxis of venous thromboembolism in bariatric surgery

    Obes Surg

    (2000)
  • H. Buchwald et al.

    Bariatric surgery: a systematic review and meta-analysis

    JAMA

    (2004)
  • D.R. Flum et al.

    Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures

    JAMA

    (2005)
  • Y.D. Podnos et al.

    Complications after laparoscopic gastric bypass: a review of 3464 cases

    Arch Surg

    (2003)
  • M.M. Samama

    An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study

    Arch Intern Med

    (2000)
  • F.A. Anderson et al.

    Risk factors for venous thromboembolism

    Circulation

    (2003)
  • B.K. Poulose et al.

    National analysis of adverse patient safety for events in bariatric surgery

    Am Surg

    (2005)
  • Prevention and management of obesity (mature adolescents and adults)

    (2005)
  • I. Arnulf et al.

    Obstructive sleep apnea and venous thromboembolism

    JAMA

    (2002)
  • P.O. Hansson et al.

    Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: “the study of men born in 1913.”

    Arch Intern Med

    (1999)
  • G. De Pergola et al.

    Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution

    Int J Obes Relat Metab Disord

    (1997)
  • Cited by (0)

    View full text